TMC125 (dapivirine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TMC125 (dapivirine), covering 2010-04-28 to 2010-04-28. Get the full timeline:
Most recent: Clinical Trial Update: TMC125-C203: Phase II Randomized (Patients Are Assigned Different Treatments Based on Chance), Placebo Controlled Dose Escalating Trial of TMC125 in HIV-1 Infected Patients [Phase 2]